Global Spinal Implants and Surgery Devices Market
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Spinal Implants and Surgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global spinal implants and surgery devices market size reached US$ 10.8 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 14.7 Billion by 2027, exhibiting a CAGR of 5.27% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Spinal implants and surgery devices refer to the medical equipment used to treat spinal deformities and disorders. These implants are manufactured using biocompatible materials, such as titanium, titanium-alloy and stainless-steel, and are commonly available in two variants, namely fusion and non-fusion implants.
Fusion implants include rods, plates, screws and interbody cages. On the other hand, non-fusion implants include artificial discs, expandable rods and growth sparing devices. Apart from this, thoracic, lumbar and cervical fusion and spinal decompression devices are also used for various treatment procedures. These implants are used to facilitate the movement of two vertebrae, improve the stability of the spine and correct deformities. The increasing prevalence of spinal disorders, such as degenerative disc disease, scoliosis, kyphosis and spondylolisthesis, is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the majority of the working population, which, in turn, is significantly increasing the incidences of obesity, back pain, posture-related problems and other degenerative spinal conditions.
Furthermore, the development of efficient growth-sparing devices, which are specifically designed for patients, especially children, who have not reached skeletal maturity is also contributing to the market growth. Additionally, various technological advancements, such as the development of advanced bone grafting products and the utilization of materials that are more durable than metal, are favoring the growth of the market. Other factors, including the rising geriatric population and widespread adoption of minimally invasive (MI) spinal surgeries, are expected to drive the market further. Key Market Segmentation Breakup by Product:
Thoracic Fusion and Lumbar Fusion Devices
Vertebral Compression Fracture Treatment Devices
Breakup by Type of Surgery:
Key Questions Answered in This Report:
How has the global spinal implants and surgery devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global spinal implants and surgery devices market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the type of surgery?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global spinal implants and surgery devices market and who are the key players?
What is the degree of competition in the industry?
Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 5 Global Spinal Implants and Surgery Devices Market 6 Market Breakup by Product 7 Market Breakup by Type of Surgery 8 Market Breakup by End User 9 Market Breakup by Region 10 SWOT Analysis 11 Value Chain Analysis 12 Porters Five Forces Analysis 13 Price Analysis 14 Competitive Landscape Companies Mentioned
B. Braun (B. Braun Holding GmbH & Co. KG)
Depuy Synthes (Johnson & Johnson)
Nuvasive Inc. (Smith & Nephew Plc)
For more information about this report visit https://www.researchandmarkets.com/r/x0f8wv
Global Spinal Implants and Surgery Devices Market
The U.S. emergency oil reserves haven’t been this low in four decades.
Investing in Warren Buffett's biggest holdings can be a winning tactic, but don't overlook the companies that occupy smaller positions in Berkshire Hathaway's portfolio.
(Bloomberg) -- China criticized expanded US restrictions on its access to semiconductor technology, saying they’ll harm supply chains and the world economy.Most Read from BloombergRussia Races to Reopen Crimea Bridge Damaged in Fiery BlastPutin Orders Sakhalin-1 Project Transferred to Russian EntityMinecraft Star Dream Meets His Screaming Fans for First TimeFacebook Is Warning 1 Million Users About Stolen Usernames, PasswordsWall Street Is Missing the Risk to Stocks If Inflation Is BeatenPreside
Residents of a small community in Vermont were blindsided last month by news that one official in their water department quietly lowered fluoride levels nearly four years ago, giving rise to worries about their children’s dental health and transparent government — and highlighting the enduring misinformation around water fluoridation. Katie Mather, who lives in Richmond, a town of about 4,100 in northwestern Vermont, said at a water commission meeting this week that her dentist recently found her two kids' first cavities. The addition of fluoride to public drinking water systems has been routine in communities across the United States since the 1940s and 1950s but still doesn't sit well with some people, and many countries don't fluoridate water for various reasons, including feasibility.
They did it to Huawei. Now, the United States is going after China's advanced computing and supercomputer industry. A little-known rule that enables U.S. regulators to extend their technology export control powers far beyond America's borders to transactions between foreign countries and China.
Prisoner advocacy group calls observation level at Ash Street Jail inadequate; says suicidal suspect Adam Howe should have been sent to Bridgewater.
Fresh blood was found on patient’s gown
One of the great things about investing in stocks is that you don't need millions of dollars in the bank to get started. Let's look at an incredible healthcare stock whose shares are changing hands for just about $44 (as of this writing): Pfizer (NYSE: PFE). Pfizer is a major pharmaceutical company with a rich lineup of medicines and vaccines.
(Bloomberg) -- Signs are piling up that the tech downturn may be deeper and longer-lasting than feared. Most Read from BloombergBiden Says Putin Threats Real, Could Spark Nuclear ‘Armageddon’Kremlin Lets State Media Tell Some Truths About Putin’s Stalling WarMusk's Twitter Takeover Hits Snag Over Debt-Financing IssueNord Stream Leaks Caused by Detonations in Sign of SabotageBiden Should Hit Saudi Arabia Where It Really HurtsAfter years of record capital spending, chipmakers are warning on a week
Exhausted nurses and staff triage an often-packed emergency room lobby at all hours, five days in to an outage of the hospital's records system.
One reason that OPEC seems comfortable cutting production to push prices higher is that the cartel is less concerned with losing market share than it was in the past.
Allogene (ALLO) starts the pivotal phase II ALPHA2 study evaluating its allogeneic CAR T therapy, ALLO-501A in patients with relapsed/refractory large B-cell lymphoma.
The White House held the Conference on Hunger, Nutrition, and Health -- the first such conference in 50 years -- on Sept. 28 to address hunger and diet-related diseases. The event comes amid a U.S....
The bull-and-bear debate around the prospects for copper and copper mining stocks, like Freeport-McMoRan (NYSE: FCX), continues to rage on. On the other hand, the bulls argue that both the demand and supply are favorable for the copper industry over the long term.
Cummins (NYSE: CMI), Caterpillar (NYSE: CAT), and Kinder Morgan (NYSE: KMI) have been through plenty of business cycles. Investing equal amounts in each industrial stock produces a dividend yield of 4.2%, while exposing your portfolio to three industry-leading businesses.
Eli Lilly (LLY) receives a fast-track designation from the FDA for tirzepatide to treat obesity in adult patients. The company will begin rolling NDA submission later this year.
Google (GOOG, GOOGL) is finally sounding off on its blockbuster $5.4 billion acquisition of cybersecurity firm Mandiant, expressing the extent of the company's ambitions in the sector.
When Sen. Lindsey Graham, R-S.C., proposed a national ban on abortions after 15 weeks of pregnancy, the bill sparked controversy across the political spectrum. But few spoke of its potential impact on the growing number of women who are having children in their 30s. The proposed ban would allow exceptions to save a woman’s life and for some pregnancies resulting from rape and incest, but it notably lacks exceptions for fetal abnormalities. As such, it would sharply restrict options for the growi
The companies that make up the S&P 500 would already be in a so-called earnings recession this year if it weren’t for higher oil prices.
A large number of U.S. COVID deaths could be prevented if patients would take Paxlovid, the antiviral developed by Pfizer that helps reduce the risk of hospitalization and death, according to White House COVID coordinator Dr. Ashish Jha.